• DOI:10.1001/jamaneurol.2014.131
Corpus ID: 1371399

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

@article{Beal2014ARC,
  title={A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.},
  author={M. F. Beal and D. Oakes and I. Shoulson and C. Henchcliffe and W. Galpern and R. Haas and J. Juncos and J. Nutt and T. Voss and B. Ravina and Clifford M Shults and K. Helles and Victoria Snively and M. Lew and Brian Griebner and A. Watts and Shan Gao and E. Pourcher and L. Bond and K. Kompoliti and P. Agarwal and Cherissa Sia and M. Jog and Linda Cole and Munira Sultana and R. Kurlan and I. Richard and C. Deeley and C. Waters and A. Figueroa and Ani Arkun and M. Brodsky and W. Ondo and C. Hunter and J. Jimenez-Shahed and A. Palao and J. Miyasaki and J. So and J. Tetrud and Liza Reys and Katharine Smith and C. Singer and Anita Blenke and D. Russell and Candace Cotto and J. H. Friedman and Margaret C Lannon and L. Zhang and E. Drasby and R. Kumar and T. Subramanian and D. Ford and D. A. Grimes and D. C{\^o}t{\'e} and J. Conway and A. Siderowf and M. Evatt and B. Sommerfeld and A. Lieberman and M. Okun and R. Rodr{\'i}guez and S. Merritt and C. L. Swartz and W. Martin and Pamela M. King and Natividad Stover and Stephanie Guthrie and R. Watts and A. Ahmed and H. Fernandez and Adrienna Winters and Z. Mari and T. Dawson and Becky Dunlop and A. Feigin and B. Shannon and M. J. Nirenberg and Mattson Ogg and S. Ellias and C. Thomas and K. Frei and I. Bodis-Wollner and S. Glazman and T. Mayer and R. Hauser and R. Pahwa and A. Langhammer and R. Ranawaya and L. Derwent and K. Sethi and Buff Farrow and R. Prakash and I. Litvan and A. Robinson and Alok Sahay and M. Gartner and V. Hinson and Samuel Markind and Melisa Pelikan and J. Perlmutter and J. Hartlein and E. Molho and S. Evans and C. Adler and A. Duffy and M. Lind and L. Elmer and K. Davis and Julia Spears and Stephanie M. Wilson and M. Leehey and N. Hermanowicz and Shari Niswonger and H. Shill and Sanja Obradov and A. Rajput and M. Cowper and S. Lessig and D. Song and D. Fontaine and C. Zadikoff and K. Williams and K. Blindauer and J. Bergholte and Clara Schindler Propsom and M. Stacy and J. Field and D. Mihăilă and Mark Chilton and E. Uc and J. Sieren and D. Simon and Lauren Kraics and A. Silver and J. Boyd and R. Hamill and C. Ingvoldstad and Jennifer K. Young and K. Thomas and S. Kostyk and Joanne Wojcieszek and R. Pfeiffer and M. Panisset and Monica Beland and S. Reich and M. Cines and Nancy Zappala and Jean Rivest and R. Zweig and L. P. Lumina and Colette Lynn Hilliard and S. Grill and Marye Kellermann and P. Tuite and S. Rolandelli and U. Kang and J. Young and J. Rao and Maureen Cook and Lawrence Severt and K. Boyar},
  journal={JAMA neurology},
  year={2014},
  volume={71 5},
  pages={
          543-52
        }
}

M. F. Beal, D. Oakes, +158 authors K. Boyar

Published 2014

Medicine

JAMA neurology

IMPORTANCE Coenzyme Q10 (CoQ10), an antioxidant that supports mitochondrial function, has been shown in preclinical Parkinson disease (PD) models to reduce the loss of dopamine neurons, and was safe and well tolerated in early-phase human studies. A previous phase II study suggested possible clinical benefit. OBJECTIVE To examine whether CoQ10 could slow disease progression in early PD. DESIGN, SETTING, AND PARTICIPANTS A phase III randomized, placebo-controlled, double-blind clinical trial… CONTINUE READING

View on PubMed

jamanetwork.com

Save to Library

Create Alert

Cite

Launch Research Feed